Genepika develops affordable, at‑home diagnostic tools that use next‑generation genetic biosensors to rapidly detect vital health biomarkers. Their platform combines non‑invasive saliva sampling with aptamer‑based and CRISPR‑enhanced sensors to deliver precise, continuous monitoring of a wide range of health indicators, enabling users to track wellness and make informed decisions about their personal health.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals lack convenient, low-cost methods for frequent at‑home monitoring of health biomarkers, relying instead on infrequent clinic visits and expensive laboratory tests. Existing at‑home tests often require invasive sampling or provide limited sensitivity, restricting early detection and continuous wellness tracking.
Solution
Genepika offers a non‑invasive saliva collection device combined with next‑generation genetic biosensors that use aptamer‑based and CRISPR‑optimized assays to detect a broad range of health biomarkers. The platform delivers high‑sensitivity, precise results within minutes, enabling users to perform regular diagnostics at home without specialized equipment. By integrating advanced genetic detection methods into an affordable, user‑friendly format, Genepika turns longitudinal biomarker analytics into a routine part of personal health management. The technology is designed for scalability, supporting future expansion to additional biomarkers and continuous monitoring applications.
Target Audience
Primary customers are health‑conscious consumers seeking regular at‑home biomarker monitoring, as well as wellness programs and tele‑health providers that require scalable, low‑cost diagnostic tools.
Features
- Disposable saliva sampling kit that requires no blood draw and can be used by consumers without training
- Aptamer‑based biosensors providing superior specificity for target proteins, metabolites, and nucleic acids
- CRISPR‑Cas assay optimized for rapid amplification and detection of genetic biomarkers directly from saliva
- Integrated readout system delivering quantitative results in minutes with cloud‑connected data storage for trend tracking
- Modular assay design allowing addition of new biomarkers as research progresses
- Cost‑effective manufacturing approach aimed at keeping per‑test pricing accessible for regular use